IRIS Accounts Production v24.1.9.2 09361760 director 1.1.23 31.12.23 31.12.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh093617602022-12-31093617602023-12-31093617602023-01-012023-12-31093617602021-12-31093617602022-01-012022-12-31093617602022-12-3109361760ns15:EnglandWales2023-01-012023-12-3109361760ns14:PoundSterling2023-01-012023-12-3109361760ns10:Director12023-01-012023-12-3109361760ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3109361760ns10:Micro-entities2023-01-012023-12-3109361760ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3109361760ns10:FullAccounts2023-01-012023-12-3109361760ns10:RegisteredOffice2023-01-012023-12-3109361760ns5:CurrentFinancialInstruments2023-12-3109361760ns5:CurrentFinancialInstruments2022-12-31
REGISTERED NUMBER: 09361760 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

MT PHARMA LIMITED

MT PHARMA LIMITED (BY SHARES) (REGISTERED NUMBER: 09361760)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023










Page

Company Information 1

Balance Sheet 2


MT PHARMA LIMITED (BY SHARES)

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTOR: Mrs M Ta





REGISTERED OFFICE: 2 Short Way
Twickenham
Middlesex
TW2 7NU





REGISTERED NUMBER: 09361760 (England and Wales)





ACCOUNTANTS: Lowson Ward
Chartered Accountants
292 Wake Green Road
Birmingham
B13 9QP

MT PHARMA LIMITED (BY SHARES) (REGISTERED NUMBER: 09361760)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
£    £   
FIXED ASSETS 2,906 3,876

CURRENT ASSETS 470,502 397,001

CREDITORS
Amounts falling due within one year (32,401 ) (26,105 )
NET CURRENT ASSETS 438,101 370,896
TOTAL ASSETS LESS CURRENT LIABILITIES 441,007 374,772

CAPITAL AND RESERVES 441,007 374,772

NOTE TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2022 - 1 ) .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MT PHARMA LIMITED (BY SHARES) (REGISTERED NUMBER: 09361760)

BALANCE SHEET - continued
31 DECEMBER 2023


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 1 August 2024 and were signed by:





Mrs M Ta - Director